Literature DB >> 17142261

Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: a functional implication for peritoneal fibrosis.

An-Hang Yang1, Seng-Wong Huang, Jin-Yang Chen, Jan-Kou Lin, Chun-Yi Chen.   

Abstract

BACKGROUND: Myofibroblastic conversion of mesothelial cells is proposed to play an important role in pathological changes following serosal membrane injury.
METHODS: Human peritoneal mesothelial cells (HPMCs) were isolated and maintained in culture. The gene expression was assessed by RT-PCR. Activation of signal transduction was determined by western blot and densitometry. Morphological changes were observed by phase-contrast and electron microscopy.
RESULTS: In vitro study showed that TGF-beta1-induced myofibroblastic growth of HPMCs was significantly enhanced in the presence of leptin. Augmented expression of alpha-smooth muscle actin, fibronectin and type I collagen mRNA in HPMCs induced by leptin were TGF-beta1-dependent, suggesting that leptin promoted peritoneal fibrogenesis through synergistic activation of the TGF-beta1 signaling system. Leptin and TGF-beta1 synergistically augmented activation of signalling components of mitogen-activated protein kinase (MAPK), STAT3 and Smad but did not modulate the expression of LEPR-B.
CONCLUSION: Leptin may act as a profibrogenic TGF-beta1 activated cytokine in peritoneal bioenvironment associated with TGF-beta1 activated pathogenic processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142261     DOI: 10.1093/ndt/gfl715

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

Review 1.  Peritoneal adipocytes and their role in inflammation during peritoneal dialysis.

Authors:  Kar Neng Lai; Joseph C K Leung
Journal:  Mediators Inflamm       Date:  2010-05-05       Impact factor: 4.711

2.  Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Mengshu Cao; Jeffery J Swigris; Xin Wang; Min Cao; Yuying Qiu; Mei Huang; Yonglong Xiao; Hourong Cai
Journal:  Mediators Inflamm       Date:  2016-08-25       Impact factor: 4.711

Review 3.  Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.

Authors:  Chih-Yu Yang; Yat-Pang Chau; Ann Chen; Oscar Kuang-Sheng Lee; Der-Cherng Tarng; An-Hang Yang
Journal:  World J Nephrol       Date:  2017-05-06

4.  Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.

Authors:  Jesús Loureiro; Pilar Sandoval; Gloria del Peso; Guadalupe Gónzalez-Mateo; Vanessa Fernández-Millara; Beatríz Santamaria; Maria Auxiliadora Bajo; José Antonio Sánchez-Tomero; Gonzalo Guerra-Azcona; Rafael Selgas; Manuel López-Cabrera; Abelardo I Aguilera
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.